1 / 12

Global Cardio-Protective Drug Market Research and Forecast, 2018-2023

Global Cardioprotective Drug Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023<br>Cardio-protective drug mainly involves in prevention of heart and blood vessel blockage which leads to heart attack, chest pain or other heart problems. Cardio-protection drug are mainly used before an ischemic event, during an ischemic event and after the event and during reperfusion. These drugs are important in the treatment of patients at risk for or with documented cardiovascular disease. Beta-blockers are indicated after acute coronary syndromes, stable coronary artery disease, heart failure, and arrhythmias. Global Cardioprotective drug market is expected to witness a significant growth during forecast period.

omrglobal
Download Presentation

Global Cardio-Protective Drug Market Research and Forecast, 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research GLOBAL CARDIO-PROTECTIVE DRUG MARKET RESEARCH AND FORECAST 2018-2023

  2. DEFINITION Cardio-protective drug mainly involves in prevention of heart and blood vessel blockage which leads to heart attack, chest pain or other heart problems.

  3. MARKET MOTIVATORS Increasing geriatric population Increasing prevalence of chronic heart diseases Increase in excessive alcohol consumption & smoking Technological advancement in healthcare

  4. MARKET RESTRAINTS High medication cost. Strict governmental regulation for drug approval.

  5. MARKET OPPORTUNITIES Increase in r&d activities by pharmaceutical companies for drug discovery. Increasing healthcare expenditure in developing nation.

  6. MARKET SEGMENTATION BY TREATMENT Cholesterol lowering Revascularization Anti-inflammatory Blood thinners & clot busters

  7. MARKET SEGMENTATION

  8. MARKET SEGMENTATION BY APPLICATION Arrhythmia Coronary artery disease Ischemic heart disease Cardiovascular disease Hyperlipidemia Peripheral heart disease Hypertension

  9. MARKET SEGMENTATION

  10. REGIONAL OVERVIEW

  11. MARKET PLAYERS AstraZeneca PLC Bristol-Myers Squibb Company GlaxoSmithKline PLC Merck & Co. Inc. Novartis AG Pfizer Inc. Sanofi S.A. Takeda Pharmaceuticals Company Ltd. To Be Continued……

  12. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/cardioprotective-drug-market/

More Related